Skye Bioscience, Inc. (SKYE)
↓ Download CSVKey ratios (FY2025)
-279.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$58.16M | -$30.19M | -$34.74M | -$18.31M | -$7.85M | -$6.29M | -$6.63M | -$4.69M | -$3.86M | -$4.47M |
| Net Income | -$55.92M | -$26.57M | -$37.64M | -$19.48M | -$8.52M | -$6.56M | $1.05M | -$19.19M | -$3.09M | -$3.18M |
| EPS (Diluted) | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 | $-0.03 | $-0.05 | $-0.16 | $-0.11 | $-0.17 |
| Total Assets | $28.31M | $72.76M | $11.94M | $9.11M | $9.86M | $2.67M | $2.00M | $1.96M | $557.2K | $323.4K |
| Total Liabilities | $8.29M | $4.61M | $14.07M | $12.12M | $3.99M | $2.22M | $1.45M | $17.52M | $1.36M | $1.77M |
| Shareholders' Equity | $20.02M | $68.15M | -$2.13M | -$3.01M | $5.86M | $450.8K | $548.1K | -$15.56M | -$3.57M | -$2.91M |
| Cash & Equivalents | $5.88M | $68.42M | $1.26M | — | — | — | — | $1.85M | $260.0K | $64.8K |
| Operating Cash Flow | -$43.06M | -$25.24M | -$13.95M | -$12.74M | -$6.47M | -$6.05M | -$6.03M | -$3.94M | -$3.33M | — |
| Capital Expenditures | $6.3K | $1.60M | $12.6K | $28.1K | $90.9K | $7.2K | — | $4.4K | $19.7K | $11.1K |
| Shares Outstanding | 33.38M | 30.97M | 12.35M | 3.65M | 476.11M | 288.07M | 182.90M | 133.91M | 33.62M | 21.56M |